Vanderbilt researcher Sheila Collins advances cardiometabolic science

By AI, Created 9:56 AM UTC, May 20, 2026, /AGP/ – Sheila Collins, a Vanderbilt University Medical Center professor in Nashville, is being highlighted for research on obesity, diabetes and heart disease, along with her mentorship of emerging scientists. Her work spans basic science, translational research and early-stage drug discovery partnerships.

Why it matters: - Collins’ research targets cardiometabolic diseases that affect millions of people, including obesity, diabetes and heart disease. - Her lab’s focus on adipocyte biology and receptor signaling connects basic biology to potential therapies. - Her mentoring of PhD students and postdoctoral fellows shapes the next generation of biomedical researchers.

What happened: - Influential Women spotlighted Sheila Collins, a professor at Vanderbilt University Medical Center in Nashville, Tennessee. - The profile highlights Collins as a nationally recognized leader in cardiometabolic disease research. - Collins works on obesity, diabetes and heart disease at the molecular level. - Her career spans academic and translational science.

The details: - Collins leads an active laboratory at Vanderbilt University Medical Center focused on adipocyte biology and receptor signaling. - Her work is designed to bridge discovery science with real-world application. - Collins mentors PhD students and postdoctoral fellows. - She reviews grant applications for major funding agencies. - She serves on editorial review panels for leading scientific journals. - Collins consults with pharmaceutical companies on early-stage discovery efforts. - Her training began as a technician at Massachusetts General Hospital, affiliated with Harvard Medical School, and at the California Institute of Technology. - Collins earned her PhD from the Massachusetts Institute of Technology, completing the degree in 1985 after starting in 1980. - She completed postdoctoral training at Duke University, specializing in receptor biology. - Collins joined the academic faculty in 1992. - She has maintained continuous involvement in biomedical research since then. - Collins emphasizes scientific integrity, collaboration and long-term impact across her work. - She values making complex scientific concepts accessible to broader audiences. - Collins advises young women entering research to gain hands-on lab experience early and choose career paths that fit personal and long-term goals.

Between the lines: - The profile presents Collins as both a scientist and a mentor, suggesting her influence extends beyond published research. - Her focus on translating basic discoveries into therapies reflects a broader pressure in biomedical research to turn lab findings into patient benefits. - Collins identifies funding as one of the field’s biggest constraints, which underscores the dependence of academic science on competitive grant support. - Her emphasis on curiosity, persistence and clear communication signals a leadership style built around training and collaboration, not just individual output.

What’s next: - Collins said the biggest opportunity in her field is moving basic discoveries toward early-stage drug development. - Collaboration with pharmaceutical companies is one route for that translation. - She will likely continue balancing research, mentorship and scientific review work at Vanderbilt. - Her public-facing profile on Influential Women and Vanderbilt’s directory offers additional background: Influential Women profile and Vanderbilt University Medical Center profile.

The bottom line: - Collins’ career blends research, mentorship and translation, making her a key example of how academic science can influence both future scientists and future therapies.